Cable Hill Partners, LLC Biogen Inc. Transaction History

Cable Hill Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 06, 2019	SELL	$219.29 - $241.72 $83,988 - $92,578	-383 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$216.71 - $338.96 $50,276 - $78,638	232 Added 153.64%	383 $91,000
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $5,870 - $7,676	-20 Reduced 11.7%	151 $51,000
Q2 2018 Aug 03, 2018	SELL	$257.52 - $306.91 $30,902 - $36,829	-120 Reduced 41.24%	171 $50,000
Q1 2018 Apr 20, 2018	SELL	$260.13 - $367.91 $25,752 - $36,423	-99 Reduced 25.38%	291 $75,000
Q4 2017 Feb 22, 2018	SELL	$307.64 - $344.58 $29,841 - $33,424	-97 Reduced 19.92%	390 $132,000
Q3 2017 Oct 27, 2017	BUY	$281.15 - $329.69 $94,747 - $111,105	337 Added 224.67%	487 $152,000
Q2 2017 Aug 14, 2017	BUY	N/A	150	150 $41,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cable Hill Partners, LLC with notifications on news.